In non-small cell lung cancer, suppression of PRDX3 induced by a ubiquitin specific peptidase-7 (USP7)-mediated manner could mitigate intracellular ROS and promote Osimertinib resistance31. Here, PRDX3 is linked to non-small cell lung carcinoma.